Royalty Financing: Fueling Biopharma Growth Without Dilution

In the evolving world of biopharma, royalty financing is emerging as a strategic alternative to traditional fundraising. Unlike equity-based models, this approach offers non-dilutive capital, allowing companies to maintain ownership while funding research, development, and commercialization. For more info: https://www.zs.com/insights/ro....yalty-financing-alte